There were 6229 patients ( 44 % ) aged 75 years with atrial fibrillation and 2 stroke risk factors randomized to warfarin ( target international normalized ratio = 2.0-3 .0 ) or rivaroxaban ( 20 mg daily ; 15 mg if creatinine clearance < 50 mL/min ) , double blind .